LifeMD Inc. (LFMD)
LifeMD Statistics
Share Statistics
LifeMD has 44.58M shares outstanding. The number of shares has increased by 7.3% in one year.
Shares Outstanding | 44.58M |
Shares Change (YoY) | 7.3% |
Shares Change (QoQ) | 0.56% |
Owned by Institutions (%) | 38.22% |
Shares Floating | 34.56M |
Failed to Deliver (FTD) Shares | 339 |
FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 4.56M, so 10.52% of the outstanding shares have been sold short.
Short Interest | 4.56M |
Short % of Shares Out | 10.52% |
Short % of Float | 13.46% |
Short Ratio (days to cover) | 6.98 |
Valuation Ratios
The PE ratio is -10.8 and the forward PE ratio is 9.73. LifeMD's PEG ratio is 0.44.
PE Ratio | -10.8 |
Forward PE | 9.73 |
PS Ratio | 0.96 |
Forward PS | 0.7 |
PB Ratio | 0 |
P/FCF Ratio | 11.64 |
PEG Ratio | 0.44 |
Enterprise Valuation
LifeMD Inc. has an Enterprise Value (EV) of 266.86M.
EV / Earnings | -14.13 |
EV / Sales | 1.26 |
EV / EBITDA | -40.11 |
EV / EBIT | -16.53 |
EV / FCF | 15.24 |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of -2.77.
Current Ratio | 0.81 |
Quick Ratio | 0.76 |
Debt / Equity | -2.77 |
Total Debt / Capitalization | 156.36 |
Cash Flow / Debt | 0 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0% and return on capital (ROIC) is 0%.
Return on Equity (ROE) | 0% |
Return on Assets (ROA) | 0% |
Return on Capital (ROIC) | 0% |
Revenue Per Employee | $698,861.31 |
Profits Per Employee | $-62,110.96 |
Employee Count | 304 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | -402K |
Effective Tax Rate | 0.02 |
Stock Price Statistics
The stock price has increased by -41.26% in the last 52 weeks. The beta is 1.5, so LifeMD's price volatility has been higher than the market average.
Beta | 1.5 |
52-Week Price Change | -41.26% |
50-Day Moving Average | 5.74 |
200-Day Moving Average | 5.7 |
Relative Strength Index (RSI) | 54.2 |
Average Volume (20 Days) | 1.19M |
Income Statement
In the last 12 months, LifeMD had revenue of 212.45M and earned -18.88M in profits. Earnings per share was -0.53.
Revenue | 212.45M |
Gross Profit | 242.4M |
Operating Income | -16.14M |
Net Income | -18.88M |
EBITDA | -6.65M |
EBIT | -16.14M |
Earnings Per Share (EPS) | -0.53 |
Balance Sheet
The company has 35,004.9B in cash and 15,218.2B in debt, giving a net cash position of 19,786.8B.
Cash & Cash Equivalents | 35,004.9B |
Total Debt | 15,218.2B |
Net Cash | 19,786.8B |
Retained Earnings | -236,253.2B |
Total Assets | 72.46M |
Working Capital | -11.52M |
Cash Flow
In the last 12 months, operating cash flow was 17.51M and capital expenditures -11.54M, giving a free cash flow of 17.51M.
Operating Cash Flow | 17.51M |
Capital Expenditures | -11.54M |
Free Cash Flow | 17.51M |
FCF Per Share | 0.43 |
Margins
Gross margin is 114.1%, with operating and profit margins of -7.6% and -8.89%.
Gross Margin | 114.1% |
Operating Margin | -7.6% |
Pretax Margin | -8.63% |
Profit Margin | -8.89% |
EBITDA Margin | -3.13% |
EBIT Margin | -7.6% |
FCF Margin | 8.24% |
Dividends & Yields
LFMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -8.86% |
FCF Yield | 6.57% |
Analyst Forecast
The average price target for LFMD is $12, which is 100.7% higher than the current price. The consensus rating is "Buy".
Price Target | $12 |
Price Target Difference | 100.7% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Stock Splits
The last stock split was on Oct 14, 2020. It was a backward split with a ratio of 1:5.
Last Split Date | Oct 14, 2020 |
Split Type | backward |
Split Ratio | 1:5 |
Scores
Altman Z-Score | -0.64 |
Piotroski F-Score | 4 |